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1. Introduction 
When aqueous solutions of D* and of PEG are 
mixed above certain concentrations immiscible, 
liquid two-phase systems are obtained [l] , with a 
PEG-rich top and a D-rich bottom phase. These can 
be buffered and are suitable for the partition, and 
separation by CCD, of cells, membrane and 
macromolecules [l-4] . Some salts (e.g., phosphate) 
distribute unevenly [S] giving rise thereby to an 
electrical and a zeta potential between the phases 
[6,7]. This phase charge interacts with membrane 
surface-charge associated properties of cells or 
membranes added to the phases [8,9]. Thus the 
partition of suspended materials is greatly (although 
not exclusively) dependent on charge. D-PEG aqueous 
phase systems can be modified and adapted to specific 
separation requirements by incorporation of D- or 
PEG-bound ligand. Derivatives that have been used 
include DEAE-dextran [ IO,1 l] and trimethylamino- 
PEG or PEG-sulfonate [12] to enhance separations 
based on charge; triton X-l 00 (a PEG derivative) 
to effect purification (by hydrophobic interaction) 
of a hydrophobic protein [ 131 ; diamidino-o, w- 
diphenylcarbamyl-PEG which, as a strong com- 
petitive inhibitor of trypsin, permits the specific 
extraction of trypsin [ 141 ; PEG-palmitate used 
*Abbreviations: D, dextran T 500; PEG, poly(ethylene glycol) 
6000; P-PEG, poly(ethylene glycol)-palmitate; RO, rightside- 
out membrane vesicles; IO, inside-out membrane vesicles; CCD, 
countercurrent distribution. 
in the extraction of serum albumin from plasma 
[1.5] ; a, w-bis-4-trimethylammonium (phenylamino)- 
PEG to purify acetylcholine receptor-enriched 
membranes [ 161 ; and DNP-PEG used in the affinity 
partition of S-23 meyloma protein [ 171 . 
In the work presented here we have examined the 
CCD patterns of sealed RO and IO human erythrocyte 
membrane vesicles in a D-PEG phase system containing 
NaCl and small quantities of P-PEG (which itself favors 
the PEG top.phase). The partition of suspended 
biological materials, in this system, depends on the 
hydrophobic interaction of the exposed membrane 
surface with the palmitoyl residue. 
RO vesicles were found to have a higher partition 
coefficient than IO vesicles reflecting difference in 
available hydrophobic residues on these two 
membrane surfaces. The data clearly indicate (a) the 
hydrophobic asymmetry of the human erythrocyte 
membrane and (b) the usefulness of hydrophobic 
affinity partition in the separation of membranes 
(and cells). 
2. Materials and methods 
2.1. Materials 
Dextran T500, lot no. 5996, was obtained from 
Pharmacia Fine Chemicals, Piscataway, N.J. PEG 
(trade name ‘Darbowax’)6000 was obtained from 
Union Carbide, New York. The synthesis of P-PEG 
has been described [ 1.51; it had an average of one 
palmitoyl residue per PEG molecule. 
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2.2. Preparation of sealed IO and RO vesicles from 
human erythrocyte membranes 
RO and IO vesicles from human erythrocyte 
membranes were prepared by the method of Steck 
[ 181. Sealed vesicles were obtained from the top of a 
dextran gradient and sidedness was established by 
measuring the acetylcholinesterase (EC 3.1.1.7) 
activity and glyceraldehyde 3-phosphate dehydrogen- 
ase (EC 1.2.1.12) activity. The former is a marker for 
the membrane outer surface while the latter is 
located on the membrane’s cytoplasmic side [ 181. 
Activities were measured in the absence and presence 
of Triton in order to determine enzyme accessibility 
on the vesicle preparations (activities without Triton 
give enzyme exposed on the vesicle surface while 
activities measured in the presence of triton give 
total vesicle enzyme activities). Enzyme activities 
were measured prior to the vesicles’ exposure to 
solutions of higher salt concentration (i.e., 0.05 M 
NaCl, see below) since glyceraldehyde 3-phosphate 
dehydrogenase is desorbed from the membrane at 
high ionic strength [18 ] . The sealed RO preparations 
were generally 100% RO; while the IO preparations 
were between 75-85% IO. 
2.3. fieparation of phase system 
The phase system was prepared as previously 
described [2] _ It contained 5% (w/w) D, 4% (w/w) 
PEG, 0.05 M NaCl, 0.001 M Na-phosphate, pH 8, 
and 0.0007% (w/w) P-PEG. The phase system was 
brought to 5°C mixed and permitted to settle in a 
separatory funnel. Top (PEG-rich) and bottom 
(D-rich) phases were then separated. 
2.4. CCD of RO and IO membrane vesicles 
The vesicles obtained after gradient centrifugation 
(see above) were washed twice (in the cold) with 0.5 
mM Na-phosphate (pH 8), after which aliquots for 
CAVITY NUMBER 
Fig.1. Superimposed countercurrent distribution patterns obtained with sealed rightside-out (o-o) and inside-out (o-0) vesicles from 
human erythrocyte membranes. Vesicles were prepared according to Steck [IS] and tested for sidedness by measuring accessibility 
of marker enzymes. 40 transfers were completed at 5°C in a phase system containing 5% (w/w) PEG, 0.05 M NaCI, 
0.001 M Na-phosphate buffer, pH 8, and 0.0007% (w/w) P-PEG. The partition of vesicles in this phase system depends on the 
hydrophobic interaction of the exposed membrane surface with the palmitoyl residue of P-PEG. For details see text. 
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enzyme determinations were withdrawn. The bulk 
of the vesicles were then washed further with a 
solution containing 0.05 M NaCl and 0.001 M Na- 
phosphate, pH 8, and finally with top phase of the 
two-phase system described above. 0.1 ml (or slightly 
less) of RO or IO membrane vesicles were suspended 
in 2 ml of top phase (load mix). A thin-layer CCD 
apparatus as described by Albertsson [ 193 and 
manufactured by Incentive Research and Development 
AB, Bromma, Sweden, was used in this work. The 
circular plexiglass plates have 120 concentric cavities, 
each with a bottom phase capacity of 0.7 ml. Cavities 
0, 1 and 60,61 each received 0.5 ml of bottom phase 
and 0.9 ml of either the RO or IO load mix. All other 
cavities received 0.6 ml bottom phase and 0.8 ml top 
phase. The unit was loaded in this manner so that a 
stationary interface would result (see [l] for full 
discussion). 40 transfers were completed using a 
settling time of 6 min, shaking time of 25 sec. The 
entire procedure was carried out at 5°C. 
2.5. Collection and analysis of membrane vesicles 
After completion of the countercurrent run, the 
samples were collected directly into plastic tubes. 
By adding saline to each tube, the two-phase system 
was converted to a single phase and the concentration 
of the membrane vesicles in selected tubes along the 
extraction train was obtained by measuring the 
absorbance at 500 nm. 
3. Results and discussion 
The D-PEG aqueous phase system selected for the 
hydrophobic affinity partition of RO and IO vesicles 
from human erythrocyte membranes contains NaCl. 
Sodium chloride partitions almost equally between 
the D and PEG phases [5] and this system therefore 
has virtually no electrical potential between the 
phases (see Introduction). If human red blood cells 
or membrane vesicles are added to such a system they 
collect at the interface. Incorporation of very small 
quantities of P-PEG (e.g., at a final concentration of 
0.001% (w/w) or even less) is adequate to effect 
usable partition coefficients for most mammalian red 
cells. The PEG backbone of P-PEG assures that the 
P-PEG will be in the top (or PEG-rich) phase and 
thus ‘pull’ membranes (or cells) ‘up’ in accordance 
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with the degree of hydrophobic interaction between 
the exposed membrane surface and the palmytoyl 
residue. That membrane charge is not involved in 
determining the partition of cells in this phase system 
(containing P-PEG and NaCl) is also shown by the 
fact that complete removal of human red cell sialic 
acid by neuraminidase treatment does not diminish 
the partition coefficient of erythrocytes [20]. 
It is evident from fig. 1 that sealed RO and IO 
vesicles have different distributions with the RO 
vesicles having the higher partition coefficient (i.e., 
being further to the right in fig.1). One can therefore 
conclude (a) that separability of membranes (and cells) 
is feasible on the basis of difference in their hydro- 
phobic surface and (b) that RO and IO vesicles have 
different exposed hydrophobic surfaces, indicative of 
membrane asymmetry (see review by Singer [21]). 
At present we do not know whether the separation in 
the present case is due to a difference in hydrophobic 
interaction between the palmitoyl residue of P-PEG 
and the RO or IO ‘general’ exposed surface, whether 
a more specific kind of palmitate receptor [22] on the 
RO vesicle surface is involved, or whether both of 
these interactions pertain. 
CCD of erythrocyte membranes in phase systems 
containing D-PEG and phosphate have also permitted 
a separation of RO and IO vesicles [23] . In this latter 
case (as in the case of membrane electrophoresis [24] ) 
the separation seems due to the membrane charge (i.e., 
sialic acid residues) present only on the membrane 
outer surface. 
It appears from the data of others (see Introduction) 
as well as the current results that polymer-ligand in 
aqueous two-phase systems is a highly useful addition 
to the arsenal of affinity separatory procedures, 
especially as applied to cells, biological particles and 
membranes. 
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